Atlas Trials

The Role of Gut Leakage Markers and Microbiota Signature in Coronary Artery Disease.

Clinical trial NCT04605627 · UNKNOWN

Trial details

NCT number
NCT04605627
Sponsor
Oslo University Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Coronary Artery DiseaseIntestinal Disease
Start date
2020-10-08
Primary completion
2021-12-31
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.